Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick S Parfrey

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trialRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Changing Health-Related Behaviors 2: On Improving the Value of Health SpendingKaren Dickson, Robert Wilson, Owen Parfrey, et al.
Kidney International|May 25, 2002
Clinical and genetic epidemiology of inherited renal disease in NewfoundlandPatrick S Parfrey, William S Davidson, Jane S Green
Methods in Molecular Biology (Clifton, N.J.)|February 20, 2015
Randomized controlled trials 1: DesignBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Journal of the American Society of Nephrology : JASN|April 24, 2001
Left ventricular hypertrophy in the renal patientRachel J Middleton, Patrick S Parfrey, Robert N Foley
Journal of the American Society of Nephrology : JASN|January 5, 2000
Contrast nephropathySean W Murphy, Brendad J Barrett, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Randomized Controlled Trials 1: DesignBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|January 24, 2009
The design of randomized controlled trialsBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Medicine|July 31, 2003
How to design a clinical trialBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapyRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trialRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Changing Health-Related Behaviors 2: On Improving the Value of Health SpendingKaren Dickson, Robert Wilson, Owen Parfrey, et al.
Kidney International|May 25, 2002
Clinical and genetic epidemiology of inherited renal disease in NewfoundlandPatrick S Parfrey, William S Davidson, Jane S Green
Methods in Molecular Biology (Clifton, N.J.)|February 20, 2015
Randomized controlled trials 1: DesignBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Journal of the American Society of Nephrology : JASN|April 24, 2001
Left ventricular hypertrophy in the renal patientRachel J Middleton, Patrick S Parfrey, Robert N Foley
Journal of the American Society of Nephrology : JASN|January 5, 2000
Contrast nephropathySean W Murphy, Brendad J Barrett, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Randomized Controlled Trials 1: DesignBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|January 24, 2009
The design of randomized controlled trialsBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Medicine|July 31, 2003
How to design a clinical trialBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapyRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Pageof 16